Replies to post #93981 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

LL gave us the approximate number who did not cross over in the control arm in her chart. Around 40%. Both arms receive SOC so they also get all the side effects from SOC. So why would the non-crossover ratios be different since Liau stated "they wished there was a larger difference" between the arms in reaching PFS?